Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relamorelin for Chronic Constipation in Parkinson's Disease (MOVE-PD)
NCT01955616Phase 2Terminated
- Sponsor
- Motus Therapeutics, Inc.
- Start
- Sep 2013
- Primary completion
- May 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of relamorelin in chronic constipation, sponsored by Motus Therapeutics, Inc.. Started Sep 2013; status: terminated.
02
Drugs
relamorelin
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT01955616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955616.